Renaissance Capital logo

TCON News

US IPO Weekly Recap: Shake Shack and Spark spike over 100% in a week with 10 IPOs

SHAK

Ten IPOs raised $1.2 billion in a week dominated by eight health care IPOs and distinguished by two deals that gained over 100% on the first day - fast casual burger chain Shake Shack and gene therapy biotech Spark Therapeutics. There were more health care IPOs...read more

TRACON Pharmaceuticals prices IPO at $10, well below $12-$14 range

TRACON Pharmaceuticals logo

TRACON Pharmaceuticals, a biotech developing combination therapies with VEGF inhibitors to treat cancers, raised $36 million by offering 3.6 million shares at $10, well below the $12 to $14 range. The company also sold 500,000 shares at the offer price to...read more

Week ahead: IPO market gains momentum with 12 deals including Shake Shack and health care

TRACON Pharmaceuticals logo

Twelve IPOs are set to raise $1 billion in the upcoming week, which would make it the busiest five-day stretch for IPOs since the week of July 28. Shake Shack's IPO offers investors a chance to own a fast-growing fast casual concept based in New York. Ten of the...read more

Cancer biotech TRACON Pharmaceuticals sets terms for $47 million IPO

TRACON Pharmaceuticals logo

TRACON Pharmaceuticals, which is developing antibodies to treat cancer, AMD and fibrotic diseases, announced terms for its IPO on Tuesday. The San Diego, CA-based company plans to raise $47 million by offering 3.6 million shares at a price range of $12 to $14....read more